Clinical characteristics and prognosis of patients with idiopathic membranous nephropathy with kidney tubulointerstitial damagearticle Published on 2023-04-262024-09-02 Journal: Renal failure [Category] 대상포진, [키워드] Cyclophosphamide cyclosporine Idiopathic membranous nephropathy tacrolimus tubulointerstitial injury [DOI] 10.1080/0886022X.2023.2205951 PMC 바로가기 [Article Type] article
Cyclophosphamide, Bortezomib, and Dexamethasone Consolidation in Patients with Multiple Myeloma after Stem Cell Transplantation: The KMM130 StudyHematologic Malignancy Published on 2023-04-162024-09-04 Journal: Cancer research and treatment [Category] 대상포진, [키워드] bortezomib consolidation Cyclophosphamide Dexamethasone Multiple myeloma [DOI] 10.4143/crt.2022.952 PMC 바로가기 [Article Type] Hematologic Malignancy
Hyperfractionated Cyclophosphamide and Dexamethasone Alone or in Combination with Daratumumab and/or Carfilzomib for the Treatment of Relapsed or Refractory Multiple Myeloma: A Single-Center Retrospective AnalysisArticle Published on 2022-12-292024-09-04 Journal: Clinical lymphoma, myeloma & leukemia [Category] 대상포진, [키워드] Carfilzomib Cyclophosphamide daratumumab Myeloma plasma cell leukemia [DOI] 10.1016/j.clml.2022.12.004 PMC 바로가기 [Article Type] Article
Managing ANCA-associated vasculitis during COVID-19 pandemic: a single-center cross-sectional studyArticle Published on 2022-12-012022-11-15 Journal: Rheumatology International [Category] 바이오마커, 진단, [키워드] Active disease ANCA-associated vasculitis Care clinical manifestations Cohort conducted COVID-19 COVID-19 infection COVID-19 severity Critical cross-sectional Cyclophosphamide death demographic died Disease activity Features Follow-up General population Immunosuppressant increased risk India Infection managing moderate non-COVID-19 patient not differ ocular outcome Patient patients patients died predicted receiving regimen required risk of COVID-19 rituximab SARS-CoV-2 severity single-center Supplemental oxygen therapy the patient Treatment Univariate analysis Vasculitis [DOI] 10.1007/s00296-022-05177-2 PMC 바로가기
Development of IgA vasculitis with severe glomerulonephritis after COVID-19 vaccination: a case report and literature reviewArticle Published on 2022-11-012022-11-15 Journal: CEN case reports [Category] 진단, [키워드] accompanied Acute kidney injury administration applied Case report COVID-19 COVID-19 pandemic COVID-19 vaccination COVID-19 vaccine Cyclophosphamide development Glomerulonephritis Hematuria IgA IgA Vasculitis IgAV. Immunosuppressive treatment initial injection Intensive intractable intravenous Japanese kidney literature review nephropathy oral steroid Patient performed Pfizer-BioNTech pulse purpura remained renal function reported resolved second dose second vaccination Spread syndrome Treatment Vasculitis [DOI] 10.1007/s13730-022-00695-1 PMC 바로가기
Severe Pancytopenia After COVID-19 Revealing a Case of Primary Bone Marrow Diffuse Large B Cell LymphomaArticle Published on 2022-09-242022-11-15 Journal: The American journal of case reports [Category] SARS, 진단, [키워드] abdominal pain absence advanced age Anemia anorexia Antibiotics B cell Blood bone Bone marrow Cell Chemotherapy Clinical deterioration Combination COVID-19 Culture Cyclophosphamide Diagnosis diarrhea died diffuse DLBCL Doxorubicin elevated fatigue Fever G-CSF granulocyte IMPROVE Infection inflammation markers initiated lymphoma malignancy management Marrow NHL Non-Hodgkin Lymphoma Pancytopenia Patient patient with COVID-19 PCR Platelet positive Prednisone Prognosis rituximab Thoracic tomography Treatment vincristine watery weight loss while White blood cell worsening [DOI] 10.12659/AJCR.937500 PMC 바로가기
Anti-factor H antibody associated hemolytic uremic syndrome following SARS-CoV-2 infectionSARS-CoV-2 감염 후 항인자 H 항체 관련 용혈성 요독 증후군Case Reports Published on 2022-09-012022-09-11 Journal: Pediatric Nephrology (Berlin, Germany) [Category] MERS, SARS, 진단, 치료기술, [키워드] Abnormalities Abstract Alternative complement pathway antibody Atypical autoantibody CFHR1 Chain Reaction complement Complement factor H related protein consecutive patient Coronavirus 19 cut-off Cyclophosphamide dialysis disease episode of estimated glomerular filtration rate Factor Factor H febrile illness filtration rate Follow-up Genetic Genetic studies glomerular filtration rate hemolytic uremic syndrome homozygous Increased information initial management median median titer mycophenolate mycophenolate mofetil New one patient pandemic Pathogenesis Patient patients plasma plasma exchanges polymerase chain polymerase chain reaction Prednisolone ranged required respiratory respiratory symptom respiratory symptoms reverse transcriptase Reverse transcriptase polymerase chain reaction RT-PCR SARS-CoV-2 SARS-COV-2 infection screened serology Specific thrombotic microangiopathy transcriptase Trigger triggered uremic syndrome [DOI] 10.1007/s00467-021-05390-4 PMC 바로가기 [Article Type] Case Reports
COVID-19 associated pediatric vasculitis: A systematic review and detailed analysis of the pathogenesisCOVID-19 관련 소아 혈관염: 병인에 대한 체계적인 검토 및 상세 분석Review Published on 2022-08-012022-09-12 Journal: Seminars in arthritis and rheumatism [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] age Analysis Arthritis article caused Central nervous system chilblain children clinical feature Coronavirus disease 2019 Corticosteroid COVID-19 criteria Cyclophosphamide Diagnosis died English Evidence Final IgA immunosuppressive drugs Inflammatory inflammatory complication majority manifestation median age MIS-C Pathogenesis Patient patients patients with COVID-19 pediatric Pediatric vasculitis phenotype Remission renal rheumatology SARS-CoV-2 secure skin subtype syndrome systematic review the patient Treatment Vasculitis was performed were excluded with COVID-19 [DOI] 10.1016/j.semarthrit.2022.152047 PMC 바로가기 [Article Type] Review
A Case Report of MPO-ANCA-Associated Vasculitis Following Heterologous mRNA1273 COVID-19 Booster Vaccination이종 mRNA1273 COVID-19 추가 백신 접종 후 MPO-ANCA 관련 혈관염 증례 보고Case Reports Published on 2022-07-042022-09-11 Journal: Journal of Korean medical science [Category] MERS, 바이오마커, 진단, [키워드] ANCA-vasculitis antibody Antineutrophil cytoplasmic antibody booster booster vaccination clinical trial constitutional symptoms coronavirus disease Coronavirus disease 2019 COVID-19 crescentic glomerulonephritis Cyclophosphamide cytoplasmic diagnosed followed by Glomerulonephritis Heterologous Increases intravenous kidney Methylprednisolone Methylprednisolone sodium succinate Moderna MPO mRNA mRNA1273 mRNA1273 COVID-19 Vaccine. past history Plasmapheresis pulse reduced regimen renal function report safety profile Side effect sodium sodium succinate steroid Symptom therapy Treatment vaccination Vaccine Vaccines Vasculitis [DOI] 10.3346/jkms.2022.37.e204 PMC 바로가기 [Article Type] Case Reports
Characteristics associated with poor COVID-19 outcomes in individuals with systemic lupus erythematosus: data from the COVID-19 Global Rheumatology Alliance전신성 홍반성 루푸스가 있는 개인의 COVID-19 결과 불량과 관련된 특성: COVID-19 Global Rheumatology Alliance의 데이터Article Published on 2022-07-012022-09-12 Journal: Annals of the rheumatic diseases [Category] Fulltext, MERS, 진단, [키워드] 95% CI Alliance Characteristics Comorbidities Comorbidity COVID-19 COVID-19 severity Cyclophosphamide death defined demographic characteristics Demographic factors determine Disease activity dose driven by Epidemiology glucocorticoid hospitalised individual Kidney disease lupus erythematosus Male sex medication methotrexate moderate multivariable multivariable model Older age ordinal logistic regression outcome outcomes Oxygenation Prednisone reported severe COVID-19 SLE systemic systemic lupus erythematosus Treatment Ventilation [DOI] 10.1136/annrheumdis-2021-221636 PMC 바로가기 [Article Type] Article